In October, the U.S. government issued Axim Biotechnologies Inc a patent for a cannabis-based suppository to treat irritable bowel syndrome.
Britain’s GW Pharmaceuticals Plc, which recently brought to market a drug derived from marijuana for epilepsy, is now seeking patent protection for another one to treat eczema.
With marijuana now fully legal in Canada and at least partially legalized in the majority of U.S. states, companies are rushing to patent new formulations of the age-old botanical. Continue reading “Patents on Pot? U.S. Lawsuit Puts Cannabis Claims to the Test”
The US hemp industry is on the verge of a groundbreaking legal victory. Powerful politicians are about to open the floodgates for billions in new sales to flow into the hemp industry in the next few years with a controversial piece of legislation.
This potential legal breakthrough is the perfect catalyst for a promising young US cannabis company that is an early leader in the high-growth hemp and CBD markets. Continue reading “Farm Bill Could Unleash $1 Billion in US Hemp Sales”
Cliff Grassmick, Daily CameraEric Haughton is chief production at Vera Cultivation, which boasts a first-of-its-kind facility that drastically reduces the amount of energy consumed in growing cannabis.
Alex Park and his two partners wanted to grow cannabis commercially without using an excessive amount of energy, a problem that has plagued indoor marijuana cultivation. Continue reading “Boulder-Based Vera Aims to Take High Energy Use out of Marijuana Cultivation Equation”
The state has awarded $2.7 million for research into how medical marijuana could replace opioids to ease chronic spinal pain — and how it might treat irritability in children and adolescents with autism.
The research will be conducted at the University of Colorado Anschutz Medical Campus, the state Department of Public Health and Environment announced this week. Continue reading “$2.7 Million Awarded for Medical Marijuana Research in Colorado”
Looks like Green Friday to us.
Get a 1-Month Trial of Cannabis Stock Trades
That’s right, an entire month to access our model portfolio which is up over 85% since we launched.
You’ll also receive exclusive analysis and investment ideas, trade alerts for our model portfolio, and the ability to chat with our analyst, Michael Vodicka, and hundreds of other cannabis traders! Continue reading “Forget Black Friday, it’s Green Friday! 1-Month Free Trial”
Massachusetts began selling recreational cannabis on November 20, 2018. If early sales are any indication the New England state is set to grow into one of the largest and fastest growing cannabis markets in the US.
According to local reports, lines were wrapped around the street and eager consumers were willing to wait in line for hours. Continue reading “Massachusetts Goes Legal – 2 Cannabis Leaders Looking to Cash In”
At this point, given our overall thesis on KushCo Holdings Inc (OTCMKTS:KSHB), we continue to look favorably on the name. That sense has only increased in response to the news that the company has formed an exclusive partnership with JSP Portinox to facilitate the delivery of ultra-pure hydrocarbon gases and solvents in state-of-the-art stainless steel gas cylinders, through its Kush Energy division, which will debut at MJBizCon November 14-16, 2018 in Las Vegas, Nevada. Continue reading “Recent Events Only Further Support the KushCo Holdings Inc (OTCMKTS:KSHB) Bull Thesis”
The first two retail marijuana shops in Massachusetts are set to begin selling products to the public Tuesday, marking the first time recreational pot will be sold east of the Mississippi.
The Massachusetts Cannabis Control Commission has given the green light to Cultivate Holdings, LLC, which has a retail shop in Leicester, and New England Treatment Access (NETA) LLC, which is readying a store in Northampton, to start selling marijuana and marijuana products. Continue reading “Recreational Marijuana Sales to Begin in Massachusetts Tuesday”
Despite majority public support in favor of marijuana legalization, and super-majority support in favor of medical cannabis access, members of Congress have nonetheless been reticent to move forward with any significant changes to federal pot policy. That is, until now. Continue reading “Congress is going to make marijuana moves”
Canopy Growth Corporation saw its shares fall 13% on Wednesday after reporting disappointing earnings that included a revenue decline. Analysts had expected better results from Canopy after Canada launched legal recreational marijuana sales on Oct. 17. Continue reading “Canopy Growth CEO says ‘For sure there’s a marijuana bubble’”